China's Ministry of Health intensifies crackdown on pharma and hospital 'bribery'

23 November 2010

Bribery in hospitals has increased in some areas of China, seriously undermining people's interests and the image of medical professionals, according to a report. In the People’s Daily last week

As a result, the Ministry of Health (MoH) will work to stop doctors receiving kickbacks from pharmaceutical companies while strictly prohibiting hospital staff from illegally collecting information about prescriptions for commercial purposes, said the report quoting an unnamed official.

"Blacklist" for alleged bribes in the pharmaceutical industry set up in June

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More ones to watch >